FindA University Ltd Featured PhD Programmes
Cardiff University Featured PhD Programmes
FindA University Ltd Featured PhD Programmes

New strategies for improving radiotherapy response in bowel cancer

   Department of Biological Sciences

This project is no longer listed on and may not be available.

Click here to search for PhD studentship opportunities
  Dr Isabel Pires  No more applications being accepted  Funded PhD Project (UK Students Only)

Hull United Kingdom Genetics Molecular Biology Radiology

About the Project

This exciting project funded by Bowel Research UK will investigate the use of clinically relevant targeted therapies as potential novel radiotherapy sensitisers in low oxygen (hypoxia) in colorectal cancer. Colorectal cancer accounts for over 10% of worldwide cancer diagnoses, with high incidence and mortality, and the presence of regions of hypoxia in tumours remain a clear obstacle in treatment for this disease.

You will join a growing and experienced research team led by Dr Isabel Pires, who has published extensively on the field of tumour hypoxia and radiobiology. This project will be closely aligned to the Adaptive Radiotherapy PhD studentship cluster at the University of Hull (also led by Dr Pires), where you will have the opportunity to engage with experts in the field of radiotherapy, molecular imaging, and clinical oncology, including the project co-supervisor Dr Rajarshi Roy, who is a Consultant Clinical Oncologist at Hull University Teaching Hospitals NHS Trust. Furthermore, this project will involve as collaborators leading academics from the University of Oxford and the University of Copenhagen.

We are looking for a highly motivated, enthusiastic, detail-oriented candidate who will have a solid knowledge base and laboratory experience in cell biology and molecular biology, and, ideally, knowledge on cancer biology and relevant laboratory experience. You must also be willing to work in a multi-disciplinary project and research environment.

About the research group

The PI and primary supervisor, Dr Isabel Pires, is a Lecturer in Biomedical Science at the University of Hull. Dr Pires’ lab is focused on the understanding of tumour hypoxia biology and its implication for tumourigenesis, therapy, and metastatic spread.

Dr Rajarshi Roy is a Consultant Clinical Oncologist at Hull University Teaching Hospitals NHS Trust and specialises in the treatment of Colorectal and Upper GI cancers and cancers of unknown primary origin. Our collaborators Dr. Marie Kveiborg (University of Copenhagen) and Professor Ester Hammond (University of Oxford) will also provide additional expertise and support to the project.

Contact Dr Isabel Pires for more information about this project. 

Eligibility and entry requirements

Applicants should have either a minimum of 2:1 undergraduate degree Biomedical Science, Cancer Biology, Biochemistry, or a related discipline with relevant experience, or have a Masters-level qualification in a relevant discipline. Experience in cancer biology laboratory techniques is desirable, but other relevant experience may also be considered.

International applicants

This opportunity comes with a Home fee waiver only.

How to apply


For details on eligibility criteria and information about how to apply, please visit the University of Hull website.


Closing date for applications

17.00 on Friday 2nd  July 2021. 

Funding Notes

The successful applicant will receive a fee waiver and a maintenance grant / stipend for three years, which covers the research period of the PhD. The fee waiver for 21/22 is £4500 (Home fee) and the maintenance grant is £15609. This rises each year in line with the UKRI’s recommended stipend allowance.
Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.